Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
P49221
UPID:
TGM4_HUMAN
Alternative names:
Fibrinoligase; Prostate transglutaminase; Prostate-specific transglutaminase; Transglutaminase P; Transglutaminase-4
Alternative UPACC:
P49221; Q16707; Q96QN4
Background:
Protein-glutamine gamma-glutamyltransferase 4, known by alternative names such as Fibrinoligase, Prostate transglutaminase, and Transglutaminase-4, plays a pivotal role in the mammalian reproductive process. It is instrumental in catalyzing the cross-linking of proteins and the conjugation of polyamines to specific proteins in the seminal tract, highlighting its critical function in fertility and reproductive health.
Therapeutic significance:
Understanding the role of Protein-glutamine gamma-glutamyltransferase 4 could open doors to potential therapeutic strategies. Its involvement in the seminal tract's biochemical processes makes it a target of interest for addressing reproductive health issues and enhancing fertility treatments.